Skip to main content
. 2021 Oct 30;8(6):4852–4862. doi: 10.1002/ehf2.13677

Figure 3.

Figure 3

N‐terminal pro‐brain natriuretic peptide with sacubitril–valsartan vs. angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers. CI, confidence interval; WMD, weighted mean difference.